328 employees
BioIVT is a worldwide provider of biological and in vitro products to pharmaceutical and biotechnology organizations
1981
$45M
from 2 investors over 2 rounds
BioIVT raised $45M on July 16, 2013
Investors: NXT Capital
BioIVT raised undisclosed on March 1, 2010
Investors: Lineage Capital